- Home
- EBS vs ICHR Comparison
EBS vs ICHR Comparison
Compare EBS & ICHR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EBS
- ICHR
- Stock Information
- Founded
- EBS 1998
- ICHR 1999
- Country
- EBS United States
- ICHR United States
- Employees
- EBS N/A
- ICHR N/A
- Industry
- EBS Biotechnology: Pharmaceutical Preparations
- ICHR Semiconductors
- Sector
- EBS Health Care
- ICHR Technology
- Exchange
- EBS Nasdaq
- ICHR Nasdaq
- Market Cap
- EBS 529.9M
- ICHR 555.0M
- IPO Year
- EBS 2006
- ICHR 2016
- Fundamental
- Price
- EBS $10.93
- ICHR $16.19
- Analyst Decision
- EBS Strong Buy
- ICHR Buy
- Analyst Count
- EBS 1
- ICHR 5
- Target Price
- EBS $15.00
- ICHR $26.50
- AVG Volume (30 Days)
- EBS 1.5M
- ICHR 1.0M
- Earning Date
- EBS 10-29-2025
- ICHR 11-03-2025
- Dividend Yield
- EBS N/A
- ICHR N/A
- EPS Growth
- EBS N/A
- ICHR N/A
- EPS
- EBS 1.35
- ICHR N/A
- Revenue
- EBS $788,900,000.00
- ICHR $957,337,000.00
- Revenue This Year
- EBS N/A
- ICHR $14.64
- Revenue Next Year
- EBS $15.42
- ICHR $5.82
- P/E Ratio
- EBS $8.11
- ICHR N/A
- Revenue Growth
- EBS N/A
- ICHR 16.86
- 52 Week Low
- EBS $4.02
- ICHR $13.12
- 52 Week High
- EBS $13.41
- ICHR $36.48
- Technical
- Relative Strength Index (RSI)
- EBS 57.23
- ICHR 46.19
- Support Level
- EBS $9.02
- ICHR $14.20
- Resistance Level
- EBS $10.29
- ICHR $15.64
- Average True Range (ATR)
- EBS 0.58
- ICHR 1.08
- MACD
- EBS -0.03
- ICHR 0.04
- Stochastic Oscillator
- EBS 93.69
- ICHR 57.50
About EBS Emergent Biosolutions Inc.
Emergent BioSolutions Inc offers public health products to the government and healthcare providers. Company operates in three segments namely Commercial Product, MCM Products, and Services segment. The Commercial Product Segment consisting of Nasal Spray; the MCM Products Segment consisting of Anthrax-MCM products, Smallpox-MCM products and Other Products and the Services Segment consisting of Bioservices portfolio. The key revenue is generated through the commercial segment which consists of NARCAN and other commercial products.
About ICHR Ichor Holdings
Ichor Holdings Ltd is engaged in the design, engineering, and manufacturing of critical fluid delivery subsystems and components for semiconductor capital equipment. The product offerings include gas and chemical delivery subsystems, collectively known as fluid delivery subsystems, which are key elements of the process tools used in the manufacturing of semiconductor devices. The company also manufactures machined components, weldments, and proprietary products for use in fluid delivery systems. Geographically, the company operates in the United States, Singapore, Europe, and Others, of which a majority of the revenue is generated from Singapore.